BB Biotech - Lower rates and news flow to support recovery
BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. It is the largest biotech investor among its...
180 Views
BB Biotech - Positive trial news lifts two portfolio holdings
In our last BB Biotech (BION) review note, published in May 2024, we noted that the biotech sector was eagerly awaiting some key milestones, the...
239 Views
BB Biotech - A recovering sector with a healthy prognosis
BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. It is the largest biotech investor among its...
206 Views
BB Biotech - A cutting-edge sector and a high dividend
BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. BION is the largest biotech investor among its...
242 Views
BB Biotech - Picking growth at good value
According to BB Biotech’s (BION’s) investment team, the biotech industry remains in a very good position. Following a sell-off in the last two...
292 Views